Song Yue, Li Yifei, Lu Liqun, Yang Changqiang, Lu Jing
Department of Pediatrics, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.
Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.
Front Pediatr. 2025 Jan 8;12:1518553. doi: 10.3389/fped.2024.1518553. eCollection 2024.
Alport syndrome (AS) is a genetically heterogeneous disorder resulting from variants in genes coding for the alpha-3/4/5 chains of Collagen IV, leading to defective basement membranes in the kidney, cochlea, and eye. The clinical manifestations of AS vary in patients. Cases of childhood AS caused by presenting primarily with nephrotic syndrome (NS) are rarely reported. Here, we report a pediatric case presenting initially with NS attributed to AS caused by .
An 11-year-old boy presented with hematuria and nephrotic range proteinuria. After excluding secondary causes, primary NS was considered. He was administered with prednisone (60 mg/day). The patient had not responded to treatment by the end of 4 weeks, so he was diagnosed with steroid-resistant NS. A renal biopsy showed granular and vacuolar degeneration of renal tubular epithelial cells, multifocal foam cell infiltration in the renal interstitium, and immunofluorescence indicated the absence of α3, α4, and α5 expression in the glomerular and tubular basement membrane, while Bowman's capsule expression was normal. Electron microscopy ultrastructural suggested variable basement membrane thickness, and partial tearing and web-like structures. Genetic testing revealed a heterozygous missense mutation c.3210 (exon 37)G>A(NM:000091). These findings are consistent with the diagnosis of AS. Prednisone was gradually tapered and enalapril maleate was initiated.
We have described a pediatric case of AS featuring NS as its primary manifestation. It is important to consider AS to be a diagnosis or differential diagnosis in patients who have NS with hematuria or steroid resistance.
Alport综合征(AS)是一种基因异质性疾病,由编码IV型胶原蛋白α-3/4/5链的基因突变引起,导致肾脏、耳蜗和眼睛的基底膜缺陷。AS的临床表现因人而异。以肾病综合征(NS)为主要表现的儿童AS病例鲜有报道。在此,我们报告一例最初表现为NS的儿科AS病例。
一名11岁男孩出现血尿和肾病范围蛋白尿。排除继发原因后,考虑为原发性NS。给予泼尼松(60mg/天)治疗。4周结束时患者对治疗无反应,因此诊断为激素抵抗性NS。肾活检显示肾小管上皮细胞颗粒状和空泡样变性,肾间质多灶性泡沫细胞浸润,免疫荧光显示肾小球和肾小管基底膜中α3、α4和α5表达缺失,而鲍曼囊表达正常。电子显微镜超微结构显示基底膜厚度可变,部分撕裂和网状结构。基因检测发现杂合错义突变c.3210(外显子37)G>A(NM:000091)。这些发现与AS的诊断一致。泼尼松逐渐减量,并开始使用马来酸依那普利。
我们描述了一例以NS为主要表现的儿科AS病例。对于有血尿或激素抵抗的NS患者,考虑将AS作为诊断或鉴别诊断很重要。